Press release
Choroidal Neovascularization Market: Insights Into Retinal Care | Top Most Keyplayers - Bausch Health Companies Inc, Bayer AG, Gilead Sciences Inc, F.Hoffmann -La Roche AG, MaaT Pharma Novartis AG, Pfizer Inc, Quark Pharmaceuticals Inc
Choroidal Neovascularization Market
Choroidal Neovascularization Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The study delves into the competitive environment, assessing leading players on their product portfolios, pricing, financial health, strategic growth initiatives, and geographic expansion.
Get a Premium Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/choroidal-neovascularization-market?ca
Choroidal neovascularization (CNV) is a condition where abnormal blood vessels grow beneath the retina and macula, often leading to vision loss. It is commonly associated with age-related macular degeneration (AMD), but can also result from other eye disorders or trauma. These new vessels are fragile and prone to leaking fluid or blood, disrupting normal retinal function. Treatments include anti-VEGF injections, laser therapy, and photodynamic therapy to slow or stop the growth of these vessels and preserve vision.
Major players in the Choroidal Neovascularization market
The prominent players in Choroidal Neovascularization market research report are: Bausch Health Companies Inc, Bayer AG, Gilead Sciences Inc, F.Hoffmann -La Roche AG, MaaT Pharma Novartis AG, Pfizer Inc, Quark Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc, Suzuken Co.Ltd.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Choroidal Neovascularization Market Dynamics
The rising prevalence of age-related macular degeneration (ARMD) and pathologic myopia is driving growth in the choroidal neovascularization market. ARMD cases are expected to more than double by 2050, especially among older adults and Hispanic populations. Pathologic myopia also shows increasing rates, with choroidal neovascularization present in up to 11.3% of cases. An aging global population, growing use of combination therapies, and the launch of long-acting anti-VEGF drugs further fuel demand. Improved healthcare infrastructure and rising R&D investments are also boosting market expansion.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/choroidal-neovascularization-market?ca
Choroidal Neovascularization Market Segments
By Product Type: Intravitreal, Intravenous
By Application: Malignant Myopia Degeneration, Extreme Myopia, Age-Related Developments
By Treatment Type: Photodynamic Therapy, Anti-VEGF therapy, Others
By Treatment Sales: Treatment Sales, Hospitals, Others
By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
The Choroidal Neovascularization industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Choroidal Neovascularization Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Choroidal Neovascularization Market: Insights Into Retinal Care | Top Most Keyplayers - Bausch Health Companies Inc, Bayer AG, Gilead Sciences Inc, F.Hoffmann -La Roche AG, MaaT Pharma Novartis AG, Pfizer Inc, Quark Pharmaceuticals Inc here
News-ID: 4041478 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market to Reach USD 93.21 Mill …
The global ESR1 mutated metastatic breast cancer diagnostics market reached USD 66.3 million in 2025 and is expected to reach USD 93.21 million by 2033, growing at a CAGR of 4.4% during the forecast period from 2026 to 2033. The market is witnessing steady growth driven by the increasing prevalence of hormone receptor-positive breast cancer and rising awareness regarding genetic mutation testing for targeted treatment. Growing adoption of precision oncology…
Oncology Molecular Diagnostics Market to Reach USD 6.46 Billion by 2033 at 6.2% …
The global oncology molecular diagnostics market reached USD 4.03 billion in 2025 and is expected to reach USD 6.46 billion by 2033, growing at a CAGR of 6.2% during the forecast period from 2026 to 2033. The market is witnessing steady growth driven by the increasing prevalence of cancer, rising demand for early and accurate diagnosis, and growing adoption of precision medicine approaches. Advancements in genomic technologies and increasing awareness…
Solar Energy Market to Reach USD 416.13 Billion by 2033 at 10.6% CAGR; Asia Paci …
The global solar energy market reached USD 190.16 billion in 2025 and is expected to reach USD 416.13 billion by 2033, growing at a CAGR of 10.6% during the forecast period from 2026 to 2033. The market is witnessing strong growth driven by increasing demand for clean and renewable energy sources, rising concerns over carbon emissions, and supportive government policies promoting solar power adoption. Rapid urbanization, growing electricity demand, and…
Zero Trust Security Market Set for Explosive Growth to US$ 137.54 Billion by 203 …
DataM Intelligence has released a new research report titled "Zero Trust Security Market Size 2026". The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in…
More Releases for Choroidal
Emerging Growth Patterns Driving Expansion in the Choroidal Neovascularization M …
The choroidal neovascularization (CNV) market is set to experience notable growth in the coming years, driven by several key factors related to advancements in treatment and diagnostic approaches. Understanding the current landscape and future outlook provides valuable insights into how this market will evolve through 2030.
Projected Market Size and Growth Trajectory of the Choroidal Neovascularization Market
The global choroidal neovascularization market is anticipated to reach a value of $5.99 billion…
Choroidal Neovascularization Market to Reach USD 18.9 Billion by 2034
Choroidal neovascularization (CNV) refers to the growth of abnormal blood vessels from the choroid into the subretinal space, commonly associated with age-related macular degeneration (AMD), high myopia, ocular trauma, and inflammatory diseases. CNV is a leading cause of vision loss in working-age and elderly populations, making it a critical focus in ophthalmology.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72251
The introduction of anti-VEGF therapies, laser photocoagulation, photodynamic therapy (PDT),…
Choroidal Neovascularization Market Size 2024 to 2031.
Market Overview and Report Coverage
Choroidal neovascularization, also known as CNV, is a condition characterized by abnormal blood vessel growth in the choroid layer of the eye, which can lead to vision loss if left untreated. The market for treatments of choroidal neovascularization is expected to grow at a CAGR of 7.00% during the forecasted period.
The future outlook for the choroidal neovascularization market is optimistic, as advancements in diagnostic…
Choroidal Neovascularization Market to Register Steady Expansion During 2017-202 …
Choroidal neovascularization is a disease that results in the formation of new blood vessels in the brunch membrane of choroid layer of eye. It occurs due to the secretion of excess amount of vascular endothelial growth factor. It can also occur, when a patient suffers with wet macular degeneration. Also, choroidal neovascularization can be caused due to genetic diseases such as optic disc drusen and pseudoxanthoma elasticum. It is also…
Choroidal Neovascularization Market to Significant Growth Foreseen by 2017 - 202 …
Choroidal neovascularization is a disease that results in the formation of new blood vessels in the brunch membrane of choroid layer of eye. It occurs due to the secretion of excess amount of vascular endothelial growth factor. It can also occur, when a patient suffers with wet macular degeneration. Also, choroidal neovascularization can be caused due to genetic diseases such as optic disc drusen and pseudoxanthoma elasticum. It is also…
CNV (Choroidal NeoVascularization) Market Set to Surge Significantly by 2023
Choroid is the part of eye that lies in between the retina (vision sensory area) and the sclera (the outer layer of the eye), this area consist of blood vessels that supply nutrients to the retinal part of our eye. Choroidal NeoVascularization (CNV) is a disease, which is characterized by the formation of new blood vessels that arise either due to the presence of Vascular Endothelial Growth Factors (VGEF) or…
